Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

New report identifies key issues with NICE’s methods for evaluating Alzheimer’s drugs

Several disease-modifying treatments for use in Alzheimer's disease are at varying stages of development and regulatory approval

- PMLiVE

Turning the UK into an mRNA superpower: what would it take?

How the UK can harness the potential of mRNA technology to play a global leading role and be a driving force of the bio-industrial revolution

- PMLiVE

A Passionate Cause: Elevating Women to Reshape Medicine

“We need more outstanding leaders from underrepresented communities, including women and those from different ethnicities”, says Antonella Chadha Santuccione, co-founder and CEO of the nonprofit Women's Brain Project in Zurich,...

Medscape Education

Mtech Access certified as a NICE META tool facilitating organisation

Mtech Access are now a certified NICE META Tool facilitating organisation, with three experts having passed the NICE assessment

Petauri Evidence

EU flag

EC approves pharmaand’s Rubraca as advanced ovarian cancer maintenance treatment

An estimated 66,000 new cases of ovarian cancer are diagnosed in Europe each year

- PMLiVE

Eli Lilly to expand injectable manufacturing capacity with new $2.5bn facility in Germany

The site is expected to be operational in 2027 and will employ up to 1,000 highly skilled workers

- PMLiVE

ABPI report shows improvement in UK industry clinical trial performance

The data showed a 15% increase in annual recruitment to UK industry clinical trials

- PMLiVE

AstraZeneca announces launch of new healthtech business Evinova to optimise clinical trials

Evinova aims to meet the needs of patients, healthcare professionals and regulators

- PMLiVE

Me and my menoPAUSE

The campaign aims to help guide conversations around the menopause in the workplace

- PMLiVE

Corporate cancer

How to put a firm’s malignancy into remission

OPEN Health unites patient engagement experts to transform the patient experience

OPEN Health unites patient engagement experts to transform the patient experience

OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement,...

OPEN Health

- PMLiVE

Pfizer and Astellas’ Xtandi approved by FDA for earlier prostate cancer indication

Xtandi is the first androgen receptor signalling inhibitor approved for this patient population

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links